Bile duct cancer, also known as cholangiocarcinoma, refers to a group of cancers that develop in the bile ducts. Bile duct cancer is rare in the United States, with about 8,000 people diagnosed ...

Cholangiocarcinoma is classically described as an irregular narrowing of the bile duct with shouldered scalloped margins. The stricture usually causes a high-grade or complete obstruction with ...

Stents to treat various blockages in the human body can themselves become blocked, but a new sensor developed at the University of Michigan for stents that are used in the bile duct may one day ...

Bile duct cancer is uncommon ... all of which had signs of changes to a protein called human epidermal growth factor receptor 2 (HER2). The research was presented by Dr. Yoshiaki Nakamura from ...

Tucatinib and trastuzumab work by blocking a protein known as human epidermal growth factor ... including that of the bile ducts. Bile duct cancer, also known as cholangiocarcinoma, affects ...

For those whose cancer has not spread beyond the bile ducts, the five-year survival rate ... tumours linked to a protein in the body called human epidermal growth factor receptor 2, or HER2.

Background: The purpose of the present study was to define the differential diagnostic markers of benign and malignant bile duct strictures without demonstrable mass on ultrasonography (US ...

An investor webcast will be held on Dec. 11 at 4:30 p.m. EST to discuss further details, according to a news release. Biliary tract cancer affects bile ducts within the gallbladder, liver and small ...

Tucatinib and trastuzumab work by blocking a protein known as human epidermal growth factor ... including that of the bile ...

RTY-694 increased protein levels and function of ABCB4 and BSEP in primary hepatocytes, two transporters that play a key role ...

For those whose cancer has not spread beyond the bile ducts, the five-year survival rate ... tumours linked to a protein in ...